At what altitude does Acute Mountain Sickness (AMS) typically occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Altitude Sickness Typically Begins at 2,500 Meters (8,200 feet)

Acute Mountain Sickness (AMS) typically begins at elevations of 2,500 meters (8,200 feet) or higher above sea level. 1 This is the threshold altitude at which most individuals become susceptible to altitude-related illness due to decreased atmospheric pressure and resulting hypoxia.

Understanding Altitude Classifications and Risk

Altitude is categorized into different levels, each with increasing risk of altitude sickness:

  • High altitude: 1,500-2,500 meters (4,900-8,200 feet) - Intermediate risk
  • Very high altitude: 2,500-5,500 meters (8,200-18,000 feet) - Significant risk
  • Extreme altitude: Above 5,500 meters (18,000 feet) - Severe risk 2

Factors Affecting Altitude Sickness Development

Several factors influence whether someone will develop AMS at the threshold altitude of 2,500 meters:

  • Rate of ascent: Rapid ascent significantly increases risk
  • Individual susceptibility: Previous history of AMS indicates higher risk
  • Method of travel: Flying directly to high altitude destinations increases risk 4.5-fold compared to gradual ascent 3
  • Physical exertion: Heavy exertion upon arrival increases risk
  • Time spent at altitude: Symptoms typically peak after the first night at altitude 4
  • Pre-existing conditions: Certain cardiovascular and respiratory conditions increase risk

Symptoms and Timing of Altitude Sickness

AMS symptoms typically develop within 1-5 days of ascent to ≥2,500 meters and include:

  • Headache (primary symptom)
  • Fatigue/lassitude
  • Dizziness
  • Nausea/vomiting
  • Sleep disturbances
  • Loss of appetite 5

Interestingly, AMS follows three distinct time course patterns:

  • Type I: Symptoms peak on day 1 (41% of cases)
  • Type II: Symptoms peak on day 2 (39% of cases)
  • Type III: Symptoms peak on day 3 (20% of cases) 4

Prevention Strategies

To prevent AMS when ascending above 2,500 meters:

  1. Gradual ascent: Limit ascent to 300-600 meters per day above 2,500 meters
  2. Acclimatization: Include rest days (one day for every 600-1,200 meters gained)
  3. Staging: Spending 2 days at intermediate altitudes (3,000-3,500m) significantly reduces AMS risk during subsequent ascent 6
  4. Medication: Acetazolamide (125-250mg twice daily) starting 24 hours before ascent 1
  5. Hydration: Maintain adequate fluid intake
  6. Avoid overexertion: Limit physical activity during first days at altitude 1

Warning Signs of Severe Altitude Illness

While mild AMS is common (affecting up to 40-60% of mountaineers), more serious conditions can develop:

  • High-altitude cerebral edema (HACE): Ataxia, severe headache, altered mental status
  • High-altitude pulmonary edema (HAPE): Persistent dry cough, shortness of breath at rest, frothy sputum

These conditions affect approximately 0.5-1.0% of visitors to elevations above 3,000 meters and require immediate descent and medical attention 7.

Special Considerations

  • Pre-existing conditions: Individuals with cardiovascular or respiratory conditions should consult a physician before traveling to high altitudes
  • Flying directly to high altitude: Consider prophylactic acetazolamide and/or staging at intermediate altitudes
  • Women: May have higher risk of AMS; iron supplementation before altitude exposure may be beneficial 1

Remember that the 2,500-meter threshold is not absolute - some individuals may experience symptoms at lower elevations, while others may remain asymptomatic at higher altitudes. However, the risk increases substantially for most people above this elevation.

References

Guideline

Prevention and Treatment of Acute Mountain Sickness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute high-altitude sickness.

European respiratory review : an official journal of the European Respiratory Society, 2017

Research

High altitude medical problems.

The Western journal of medicine, 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.